Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

When insurance says no, some patients are skipping the appeals process and going straight to the CEO's inbox — and it's paying off. Two recent cases highlight how escalating denials to company leadership can unlock approvals that traditional channels couldn't. Experts say the tactic works, but warn it shouldn't have to.
When insurance companies deny claims, most patients fight back through formal appeals — but a growing number are trying a different route: emailing the CEO directly. Two recent success stories, highlighted by former insurance executive Wendell Potter, show this unconventional strategy can actually work. Elizabeth Nicholas, a 36-year-old breast cancer patient, emailed her insurer's CEO after her recommended chemotherapy was denied — and quickly received approval from the company's chief scientific officer. Donald Grant, a 49-year-old with a rare spinal condition, used an AI-assisted appeals platform to craft an 11-page legal and medical argument, sent it to UnitedHealth Group's CEO, and CC'd legislators and journalists — and his out-of-network surgery with a leading specialist was approved at the in-network rate.
Potter explains that major insurers maintain dedicated teams to handle high-profile or C-suite-escalated cases, meaning these cases get special attention that standard appeals often don't. He notes that physicians may have an edge in navigating the system, though repeatedly challenging insurers carries its own risks, including potential removal from networks.
Key Takeaways:
Why it matters: These stories expose a troubling reality: getting medically necessary care often requires extraordinary effort and insider knowledge. For clinicians, understanding these escalation tactics could be a powerful tool for advocating on behalf of patients — even as experts push for broader systemic change.